ListarArtículos (Medicina Preventiva y Salud Pública) por materia "Biosimilar agent"
Mostrando ítems 1-1 de 1
-
Artículo
Switching from reference infliximab to CT-P13 in patients with inflammatory bowel disease: results of a multicenter study after 12 months
(Aran Ediciones S.A., 2018)Background and aims: infliximab has changed the natural history of inflammatory bowel disease (IBD). The advent of ...